Clinical Trial Update: A Study of Soticlestat in Adults and Children With Rare Epilepsies [Phase 2]

View source ↗

Summary

Takeda reports termination of a Phase 2 study of Soticlestat in adults and children with rare epilepsies, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• Soticlestat (soticlestat)

Snippet

Sponsor: Takeda | Conditions: Epilepsy, Dravet Syndrome (DS) | Phase 2 | Status: TERMINATED | Results posted: 2026-03-19